I asked chatGPT for some questions to ask ( I'm not smart enough to come up with my own)
I think most of these have been asked/answered previously.
Overview of the Drug:
- Can you provide a overview of the drug, including its mechanism of action, unique features, and any advantages over existing treatments?
Clinical Trial Progress:
- What is the current status of the drug's clinical trials, and can you share any recent developments or milestones achieved?
- Are there any upcoming catalysts or events related to the clinical trials that investors should be aware of?
Reformulation and Additional Uses:
- How does the reformulation of the drug enhance its usability and effectiveness?
- Can you discuss the potential of the drug for cardio protection and any other applications being explored?
Market Potential:
- What is the estimated market size for the reformulated drug, and how does the company plan to capture a significant share of that market?
- Are there any partnerships or collaborations in place to facilitate market penetration?
Regulatory Pathway:
- Can you outline the regulatory pathway for the drug's approval? Are there any potential challenges or risks associated with the regulatory process?
Commercialization Plans:
- What are the company's plans for commercializing the drug once it receives regulatory approval?
- Can you provide a timeline for when the drug is expected to reach the market?
Competitive Landscape:
- How does the drug compare to existing treatments in terms of efficacy, safety, and cost-effectiveness?
- What sets the company apart from competitors working on similar therapies?
Financial Viability:
- How is the company funded, and what is its financial strategy to support the drug's development and commercialization?
- Can you discuss the company's financial stability and its ability to navigate potential challenges?
Intellectual Property Protection:
- What measures has the company taken to protect its intellectual property related to the drug?
- Are there any concerns regarding potential patent challenges or infringements?
Risks and Mitigation Strategies:
- What are the main risks associated with the development and commercialization of the drug, and how does the company plan to mitigate these risks?
- How does the management team plan to address unforeseen challenges that may arise during the drug development process?
- Forums
- ASX - By Stock
- RAC
- RAC media coverage
RAC media coverage, page-1908
-
-
- There are more pages in this discussion • 357 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.73 |
Change
0.030(1.76%) |
Mkt cap ! $292.8M |
Open | High | Low | Value | Volume |
$1.74 | $1.75 | $1.70 | $154.6K | 89.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | $1.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.73 | 2382 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4259 | 1.720 |
1 | 6303 | 1.715 |
1 | 9600 | 1.710 |
4 | 11134 | 1.700 |
1 | 449 | 1.695 |
Price($) | Vol. | No. |
---|---|---|
1.730 | 2798 | 2 |
1.735 | 5439 | 1 |
1.740 | 9302 | 2 |
1.750 | 3460 | 3 |
1.755 | 4423 | 1 |
Last trade - 14.31pm 25/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |